Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension”

815 trials

Showing 20 of 815 results

Not applicableStudy completedNCT01266265
What this trial is testing

Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 1,333
Not applicableStudy completedNCT03888365
What this trial is testing

Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 43
Testing effectiveness (Phase 2)Study completedNCT00990314
What this trial is testing

Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients

Who this might be right for
Pulmonary Arterial Hypertension
Lung Biotechnology PBC 31
Large-scale testing (Phase 3)WithdrawnNCT02999906
What this trial is testing

Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics
Not applicableStudy completedNCT04094272
What this trial is testing

Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection

Who this might be right for
Pulmonary Artery HypertensionChronic Hepatitis c
Kantonsspital Olten 49
Not applicableUnknownNCT03841344
What this trial is testing

Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH

Who this might be right for
Pulmonary Arterial Hypertension
University of Sheffield 44
Early research (Phase 1)Study completedNCT04991181
What this trial is testing

Absorption, Distribution, Metabolism and Excretion of BIA 5-1058

Who this might be right for
Pulmonary Arterial Hypertension
Bial - Portela C S.A. 15
Not applicableStudy completedNCT02371733
What this trial is testing

Aerobic Exercise Training in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Gazi University 30
Not applicableStudy completedNCT01959815
What this trial is testing

Novel Screening Strategies for Scleroderma PAH

Who this might be right for
Pulmonary Arterial HypertensionScleroderma
University of Michigan 156
Not applicableLooking for participantsNCT01501838
What this trial is testing

Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires

Who this might be right for
Hypertension, Pulmonary Arterial
Hospital Italiano de Buenos Aires 200
Not applicableStudy completedNCT05124015
What this trial is testing

Exercise Capacity Respiratory Muscle Strength Dyspnea and Physical Activity in Pediatric Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Gazi University 33
Not applicableStudy completedNCT01721564
What this trial is testing

Bosentan and Pulmonary Endothelial Function

Who this might be right for
Pulmonary Arterial Hypertension
Prof David S Celermajer 8
Not applicableStudy completedNCT06907693
What this trial is testing

The Effects of Drug Candidate CS1 on Lung Structure and Function Utilizing FRI

Who this might be right for
Pulmonary Arterial Hypertension
Prisma Health-Upstate 7
Early research (Phase 1)Looking for participantsNCT05967299
What this trial is testing

Study of Intravenous ZMA001 in Healthy Subjects

Who this might be right for
Pulmonary Arterial Hypertension PAH
National Heart, Lung, and Blood Institute (NHLBI) 96
Not applicableStudy completedNCT02826252
What this trial is testing

Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)

Who this might be right for
Hypertension, Pulmonary
Bayer 64
Testing effectiveness (Phase 2)Study completedNCT00423592
What this trial is testing

Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Gilead Sciences 36
Early research (Phase 1)Study completedNCT02551653
What this trial is testing

Positron Emission Tomography (PET) Study to Evaluate Biodistribution of [11C]-GSK2256098 in Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patients

Who this might be right for
Hypertension, Pulmonary
GlaxoSmithKline 10
Not applicableActive Not RecruitingNCT06543745
What this trial is testing

Safety and Impact of Low Resistance Exercise Training on Quality of Life in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial HypertensionFrailty
University of Pennsylvania 20
Early research (Phase 1)Study completedNCT03950739
What this trial is testing

Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 51
Large-scale testing (Phase 3)Ended earlyNCT00302211
What this trial is testing

The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Actelion 67
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation